PosterPerspectives: NSCLC Posters and Abstracts from Chicago
The following abstracts and posters were curated from all the posters presented at the 2015 American Society of Clinical Oncology meeting. The posters look at a several issues in the treatment of non-small cell lung cancer (NSCLC). Specifically, the posters we selected highlight the potential role of new and emerging drugs and combination strategies, treatment among patients with specific tumor subtypes, and long-term outcomes among patients with advanced disease.
Corey Langer, MD, professor of internal medicine and director of Thoracic Oncology at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia.
Heather Wakelee, MD, associate professor of medicine, Division of Oncology, Stanford University, Palo Alto, California.
National audience of oncologists and other health care providers who manage patients with non-small cell lung cancer.
At the conclusion of this activity, participants should be better able to:
- Summarize the latest research developments in the diagnosis and treatment of non-small cell lung cancer (NSCLC)
- Apply evidence-based research into clinical practice to improve quality of care and clinical outcomes
You may participate by listening to any-or all-of the audio discussions. Click the 'Play' button to hear our faculty review the data and clinical implications of each poster/abstract. Two questions will appear at the end of each discussion. When ready to claim your CE/CME credit, complete the "Program Evaluation" first (required) and then click on "Certificate" button to download your certificate
This activity is supported by an independent educational grant from AstraZeneca.
Supported by an educational grant from Genentech.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
- 2.50 AMA PRA Category 1 Credit(s)™
- 2.50 Attendance